Richard A. Williams
-
Senior Affiliated Scholar
Richard Williams is a Senior Affiliated Scholar, the former Director of the Regulatory Studies Program, and the former Vice President of Policy Research at the Mercatus Center at George Mason University. He is an expert in benefit-cost analysis and risk analysis, particularly associated with food safety and nutrition. In 2021 he authored, “Fixing Food: An FDA Insider Unravels the Myths and the Solutions.”
Williams has testified before the US Congress and addressed numerous international governments, including those of the United Kingdom, China, South Korea, Yugoslavia, and Australia. His media appearances have included NPR, Reuters, Bloomberg, the New York Times and the Wall Street Journal.
Before joining the Mercatus Center, Williams was the director for social sciences at the Center for Food Safety and Applied Nutrition in the Food and Drug Administration (FDA) where he worked for 27 years. He also was an adviser to the Harvard Center for Risk Analysis and taught economics at Washington and Lee University. He is a US Army veteran who served in Vietnam.
Latest Work
- | Regulation Regulation
- | Expert Commentary Expert Commentary
How Congress Can Bridge the Divide: Face Each Other and Talk | The Hill
- | Regulation Regulation
- | Expert Commentary Expert Commentary
Access to Weight-loss Drugs Could Drastically Improve Societal Equity | The Washington Post
- | Expert Commentary Expert Commentary
The Infant Formula Blame Game | The Hill
- | Government Spending Government Spending
- | Expert Commentary Expert Commentary
The IRS Doesn’t Need More Workers, It Needs Less Work | The Courier-Times
- | Expert Commentary Expert Commentary
Can the FDA Regulate Away the Perils of Outdoor Crops? | The Hill
- | Expert Commentary Expert Commentary
Nutrition Policy Without Politics | The Eagle-Tribune
- | Expert Commentary Expert Commentary
The Next Economic Battle: Striving for Simplicity
- | Expert Commentary Expert Commentary
Nutrition Science Moves On
Latest Work
- | Regulation Regulation
- | Expert Commentary Expert Commentary
How Congress Can Bridge the Divide: Face Each Other and Talk | The Hill
- | Regulation Regulation
- | Expert Commentary Expert Commentary
Access to Weight-loss Drugs Could Drastically Improve Societal Equity | The Washington Post
- | Expert Commentary Expert Commentary
The Infant Formula Blame Game | The Hill
- | Government Spending Government Spending
- | Expert Commentary Expert Commentary
The IRS Doesn’t Need More Workers, It Needs Less Work | The Courier-Times
- | Expert Commentary Expert Commentary
Can the FDA Regulate Away the Perils of Outdoor Crops? | The Hill
- | Expert Commentary Expert Commentary
Nutrition Policy Without Politics | The Eagle-Tribune
- | Expert Commentary Expert Commentary
The Next Economic Battle: Striving for Simplicity
- | Expert Commentary Expert Commentary
Nutrition Science Moves On
Latest Work
- | Regulation Regulation
- | Policy Briefs Policy Briefs
Helping Small Businesses Comply with Federal Regulations
- | Regulation Regulation
- | Working Papers Working Papers
Government Dietary Guidelines
- | Regulation Regulation
- | Working Papers Working Papers
Regulation under Uncertainty
- | Medical Innovation Toolkit Medical Innovation Toolkit
- | Regulation Regulation
- | Working Papers Working Papers
Health Options Foreclosed: How the FDA Denies Americans the Benefits of Medical Research
- | Medical Innovation Toolkit Medical Innovation Toolkit
- | Regulation Regulation
- | Data Visualizations Data Visualizations
Does FDA Funding Increase Drug and Medical Device Innovation?
- | Academic & Student Programs Academic & Student Programs
- | Medical Innovation Toolkit Medical Innovation Toolkit
- | Regulation Regulation
- | Data Visualizations Data Visualizations
How Productive Is the FDA’s Devices Program?
- | Medical Innovation Toolkit Medical Innovation Toolkit
- | Regulation Regulation
- | Data Visualizations Data Visualizations
How Productive Is the FDA’s Human Drugs Program?
- | Medical Innovation Toolkit Medical Innovation Toolkit
- | Regulation Regulation
- | Data Visualizations Data Visualizations
More FDA Spending Does Not Necessarily Mean Better Results
- | Regulation Regulation
- | Research Papers Research Papers
US Medical Devices: Choices and Consequences
- | Medical Innovation Toolkit Medical Innovation Toolkit
- | Regulation Regulation
- | Data Visualizations Data Visualizations
Maze of FDA Regulations Slows Medical Innovation to a Crawl
Latest Work
- | Academic & Student Programs Academic & Student Programs
- | Regulation Regulation
- | Public Interest Comments Public Interest Comments
It’s Time to Rethink the Nutrition Facts Panel
- | Regulation Regulation
- | Public Interest Comments Public Interest Comments
A First Step: Issues with Implementing the Executive Order to Reduce Regulation
- | Regulation Regulation
- | Federal Testimonies Federal Testimonies
Federal Regulation of Food Safety
- | Regulation Regulation
- | Public Interest Comments Public Interest Comments
Retrospective Analysis of the Regulations Implementing the Nutrition Labeling and Education Act of 1990
- | Regulation Regulation
- | Federal Testimonies Federal Testimonies
David vs. Godzilla, OIRA, and the Federal Agencies
- | Regulation Regulation
- | Federal Testimonies Federal Testimonies
OIRA Alone Could Not Achieve President Carter's Goals
- | Regulation Regulation
- | Public Interest Comments Public Interest Comments
Comment on OMB's Draft 2013 Report to Congress on the Benefits and Costs of Federal Regulations
- | Regulation Regulation
- | Public Interest Comments Public Interest Comments
Solving Food Safety Problems Without Antiquated Regulation and Inspection
- | Regulation Regulation
- | Public Interest Comments Public Interest Comments
Comment on OMB's Draft 2012 Report to Congress on the Benefits and Costs of Federal Regulations
- | Regulation Regulation
- | Federal Testimonies Federal Testimonies
Office of Information and Regulatory Affairs: Federal Regulations and Regulatory Reform under the Obama Administration
Latest Work
- | Regulation Regulation
- | Expert Commentary Expert Commentary
How Congress Can Bridge the Divide: Face Each Other and Talk | The Hill
- | Regulation Regulation
- | Expert Commentary Expert Commentary
Access to Weight-loss Drugs Could Drastically Improve Societal Equity | The Washington Post
- | Expert Commentary Expert Commentary
The Infant Formula Blame Game | The Hill
- | Government Spending Government Spending
- | Expert Commentary Expert Commentary
The IRS Doesn’t Need More Workers, It Needs Less Work | The Courier-Times
- | Expert Commentary Expert Commentary
Can the FDA Regulate Away the Perils of Outdoor Crops? | The Hill
- | Expert Commentary Expert Commentary
Nutrition Policy Without Politics | The Eagle-Tribune
- | Expert Commentary Expert Commentary
The Next Economic Battle: Striving for Simplicity
- | Expert Commentary Expert Commentary